Trial intelligence / Profile preview

Re-oxygenation after Kalinox in Dental Care

NCT00643786Phase 3Terminated

Sponsor
Air Liquide
Start
Feb 2004
Primary completion
May 2007
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 3, randomised trial of nitrous oxide + oxygen in Dental anxiety (2 arms), sponsored by Air Liquide. Primary endpoint: Oxygen Saturation. Started Feb 2004; status: terminated.

02

Drugs

nitrous oxide + oxygen
03

Conditions

Dental anxiety

Beyond the preview

Go deeper on NCT00643786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00643786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call